GH1 and Alzheimer disease: In the AD group, GH levels (3.78 ± 2.8 ng/mL) were significantly higher than those observed in the CD group (1.09 ± 0.86 ng/mL, p = 0.006) and the RD group (0.87 ± 0.56 ng/mL, p = 0.004).